Biofluids Research Group, Department of Biomedical Engineering, Stony Brook University, T8-050 Health Sciences Center, NY, 11794-8084, Stony Brook, USA.
Department of Cardiology, Rabin Medical Center, Petah Tikva, Israel, 4941492.
J Cardiovasc Transl Res. 2022 Aug;15(4):834-844. doi: 10.1007/s12265-021-10191-z. Epub 2021 Dec 2.
Bicuspid aortic valve (BAV), the most common congenital valvular abnormality, generates asymmetric flow patterns and increased stresses on the leaflets that expedite valvular calcification and structural degeneration. Recently adapted for use in BAV patients, TAVR demonstrates promising performance, but post-TAVR complications tend to get exacerbated due to BAV anatomical complexities. Utilizing patient-specific computational modeling, we address some of these complications. The degree and location of post-TAVR PVL was assessed, and the risk of flow-induced thrombogenicity was analyzed in 3 BAV patients - using older generation TAVR devices that were implanted in these patients, and compared them to the performance of the newest generation TAVR devices using in silico patient models. Significant decrease in PVL and thrombogenic potential was observed after implantation of the newest generation device. The current work demonstrates the potential of using simulations in pre-procedural planning to assess post-TAVR complications, and compare the performance of different devices to achieve better clinical outcomes. Patient-specific computational framework to assess post-transcatheter bicuspid aortic valve replacement paravalvular leakage and flow-induced thrombogenic complications and compare device performances.
二叶式主动脉瓣(BAV)是最常见的先天性瓣异常,它会产生非对称的流动模式,并增加瓣叶的应力,从而加速瓣钙化和结构退化。经改良后应用于 BAV 患者的经导管主动脉瓣置换术(TAVR)表现出良好的效果,但由于 BAV 的解剖结构复杂,TAVR 术后的并发症往往更为严重。我们利用患者特异性计算模型来解决其中的一些并发症问题。通过对 3 名 BAV 患者进行研究,评估了 TAVR 术后的瓣周漏(PVL)程度和位置,并分析了血流诱导的血栓形成风险,同时还使用植入这些患者的上一代 TAVR 设备对其进行了分析,并将其与使用计算机模拟患者模型的最新一代 TAVR 设备的性能进行了比较。研究结果显示,在植入新一代设备后,PVL 和血栓形成的风险显著降低。本研究证明了在术前规划中使用模拟技术评估 TAVR 术后并发症,并比较不同设备性能以获得更好的临床效果的潜力。